Reckitt Raises Guidance Following Sharp Improvement In Cold & Flu Sales
A sharp improvement in cold and flu sales trends in the third quarter has prompted Reckitt to increase its sales guidance for the full year. However, the UK-based firm is warning that these trends remain unpredictable for the remainder of 2021.
You may also be interested in...
Reckitt is to divest its Chinese infant formula business in a deal worth $2.2bn following a strategic review of the troubled unit.
Sweden's Karo Pharma is acquiring Sylphar Group and its dietary supplement and beauty brands sold around Europe, primarily online.
AESGP Regulatory Conference: EU Pharma Strategy, Med Devices Regs, European Green Deal And GCSF Sustainability Charter Launch
HBW Insight reports on a packed agenda at the AESGP's Regulatory Conference on 25 November. Panels discuss the implications of raft of legislative changes for the European self-care industry, including the incoming EU Pharmaceutical Strategy, the new Medical Devices Regulations, and the inter-related European Green Deal, Farm to Fork and Chemicals Strategies. The conference also saw the launch of the GSCF's Charter for Environmentally Sustainable Self-Care.